Home / Health / New Asthma Trigger Found: Pseudo Leukotrienes Identified
New Asthma Trigger Found: Pseudo Leukotrienes Identified
28 Jan
Summary
- Scientists discovered new molecules called pseudo leukotrienes linked to asthma.
- These molecules may be more significant than previously known leukotrienes.
- Pseudo leukotrienes were four to five times higher in asthma patients.
Scientists at Case Western Reserve University have identified previously unknown molecules, termed pseudo leukotrienes, that may be a primary driver of asthma-related inflammation. This groundbreaking discovery, published in the Journal of Allergy and Clinical Immunology, challenges decades of focus on leukotrienes. Pseudo leukotrienes are generated through a different chemical pathway, involving free radicals interacting with lipids, unlike the enzyme-driven leukotrienes. Their levels were found to be four to five times higher in individuals with asthma compared to those without, correlating with disease severity. This suggests a potential new avenue for diagnostics and treatment.
Current asthma medications often target the receptor that both leukotrienes and pseudo leukotrienes activate, leading to airway tightening. However, the researchers propose that future therapies could focus on modulating or preventing the free radical process responsible for pseudo leukotriene formation. This approach might offer a more targeted treatment, avoiding potential side effects of broadly blocking inflammation. The team plans further research to explore pseudo leukotrienes' role in other respiratory conditions.
